Skip to main content

Crack GPAT — Prepare for GPAT Online 

FDA approves 1st drug for thymidine kinase 2 deficiency, a very rare mitochondrial disease

The U.S. Food and Drug Administration (FDA) approved Kygevvi (doxecitine and doxribtimine) powder to treat thymidine kinase 2 deficiency (TK2d) in adults and pediatric patients who start to show symptoms when they are 12 years old or younger. Kygevvi received Breakthrough Therapy Designation for this indication.

M.Pharm, MTech, MSc Openings under Ministry of Science & Technology - Salary Rs. 49,560 month
Candidates having M.Sc. / M.Tech / M.Pharm. / M.V.Sc. or equivalent qualification in Life Sciences or allied subjects (Biochemistry / Biotechnology / Virology / Bioinformatics / Computational Biology / Microbiology, etc.)
Faculty openings at Gyan Vihar School pharmacy - Pharmaceutics, Pharmacology, Pharmaceutical Chemistry, Pharmacognosy
Ph.D. for the position of Assistant Professor, Associate Professor and Professor in the following specialization Pharmaceutics, Pharmacology, Pharmaceutical Chemistry, Pharmacognosy. Gyan Vihar School of Pharmacy, Jaipur
Advertisement for Pharmacist under District Health Committee
Degree or Diploma in Pharmacy (50%) & Registration in Pharmacy Registration Council.
Opportunity for M.Pharm, MS Pharm, Pharm.D, MSc as JRF at AIIMS
M.Pharm / MS Pharm / Pharm.D / MSc or Equivalent with specialization in Biochemistry/ Biotechnology/Microbiology or Life sciences. 
Career for Pharmacist at All India Institute of Medical Sciences
Diploma in Pharmacy from a recognised University / Institution. Should be a registered Pharmacist under Pharmacy Act 1948.
Advertisement for MSc / MTech Life Sciences candidates at Indian Institute of Technology
M.Sc / M.Tech. in any field related to life sciences. Candidate must be NET / GATE qualified. Experience in molecular biology and structural biology techniques including cloning, expression, purification of proteins will be preferred
Institute of Liver and Biliary Sciences looking for Life Sciences candidates | Salary 31,000 per month
Graduate in Life Sciences from a recognized university; Three years work experience from a recognized institution. 
Applications are invited for Research Scientist at NII - Salary Rs. 72,800 month
PhD in any area of Life Sciences or Masters with minimum three years of experience. Candidate with first author publication in a reputed journal will be preferred. 
Application for JRF- CSIR Project at BITS Pilani Campus
First class in Masters Degree with specialization in Cancer Biology / Epigenetics / Molecular Biology / Cell Biology / Nanoscience and Nanotechnology from a recognized University with good knowledge of molecular biology.
Walk in Drive for M.Pharm, B.Pharm, MSc in formulations manufacturing facility at USV Private Limited
Having good exposure in the OSD facility, documentation and handling equipment such as FBD / FBP / Glatt/ Fette/ Korsch)
Walk-in for Fresher D.Pharm, B.Pharm, M.Pharm M.Sc in Production, QC, Fermentation at Macleods
Walk in for Fresher M.Sc (Analytical Chemistry), M.Sc.(Microbiology), B.Pharma, M.Pharma
Walk in for B.Pharm, M.Pharm, BSc in Production at Emcure
Exposure to Leak Test/ Skid Operations/ Filling/ Vial Washing, Exp of Handling Isolator/ VHP Based Filling Area
Dr. Reddy’s Laboratories | Career Expo in Ahmedabad for B.Pharm, MSc, BSc, BTech candidates
Diploma/ B Tech, B.sc, MSc, B.Pharm, BTech or Masters in Biotechnology / Microbiology /Biochemistry
Dr. Reddy’s Laboratories Require QC Team Member - M.Pharm, B.Pharm, MSc apply
Implement and maintain quality control procedures within the QMS framework. Conduct thorough inspections and tests on products and materials at various stages of production
Interview for D.Pharm, M.Sc, B.Sc in Production, Warehouse at Granules India
WALK-IN INTERVIEW for Diploma / D.Pharm/ B.Sc / MSc Production, Warehouse & Engineering (OSD Formulations)
Pfizer Sues Metsera and Novo Nordisk over alleged breach of merger deal
Pfizer Inc. announced that it has filed a lawsuit against Metsera, Inc., its Board of Directors, and Novo Nordisk, S.A. in the Delaware Court of Chancery. The lawsuit includes claims for breach of contract, breach of fiduciary duty, and tortious interference in contract arising from Metseras alleged breach of its obligations under the merger agreement between Pfizer and Metsera.
Ozempic cuts heart risks even without weight loss
Semaglutide significantly reduced major adverse cardiovascular events in patients with overweight or obesity with cardiovascular disease but without diabetes, as per recent research study conducted by University College London.
FDA Takes Action to Protect Children from Unapproved Fluoride Medications
The U.S. Food and Drug Administration today announced actions to restrict the sale of unapproved ingestible fluoride prescription drug products for children. The FDA sent notices to four companies outlining the agencys intention to take enforcement action against those marketing unapproved fluoride-containing ingestible drugs labeled for use in children under age 3 or older children at low or moderate risk for tooth decay.
UK patient first to trial CAR T cell therapy to treat multiple sclerosis
A multiple sclerosis patient in the UK was the first to receive CAR T cell therapy, invented by UCL researchers, in a clinical trial testing whether this personalised treatment can slow or even halt the progression of the disease.
Subscribe to